Report Detail

Medical Devices & Consumables Global Lentivirus Preparations Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4679711
  • |
  • 26 February, 2026
  • |
  • Global
  • |
  • 138 Pages
  • |
  • GIR
  • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Lentivirus Preparations market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Lentivirus preparations refer to viral vectors derived from lentiviruses, a type of retrovirus. These preparations are commonly used in molecular biology and gene therapy applications to introduce genetic material into target cells. Lentiviral vectors are known for their ability to efficiently transduce both dividing and non-dividing cells, making them valuable tools for stable gene transfer. Lentivirus preparations typically involve the production of viral particles in a host cell culture, followed by purification and concentration processes to obtain a high-quality vector. Lentiviral vectors have been widely utilized in various research studies and therapeutic approaches, including the delivery of genes for gene therapy, functional genomics, and the development of genetically modified cells for biomedical applications.
The cell and gene therapy market is experiencing significant growth driven by ongoing advancements in medical research and biotechnology. Key trends include an increasing number of clinical trials and approvals for cell and gene therapies, indicating a growing acceptance of these innovative treatments. There is a notable emphasis on personalized medicine, with therapies tailored to individual patients based on genetic factors. Collaborations and partnerships between pharmaceutical companies and research institutions are on the rise, fostering innovation and the development of novel therapies. Manufacturing scalability and process optimization are focal points to meet the rising demand for these therapies. Additionally, efforts to address regulatory and reimbursement challenges are ongoing, reflecting the dynamic nature of the cell and gene therapy landscape. Overall, the market is evolving rapidly, with a focus on expanding therapeutic applications and improving accessibility for patients globally.
This report is a detailed and comprehensive analysis for global Lentivirus Preparations market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Lentivirus Preparations market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Lentivirus Preparations market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Lentivirus Preparations market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Lentivirus Preparations market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Lentivirus Preparations
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Lentivirus Preparations market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Addgene, Abm (Applied Biological Materials), System Biosciences (SBI), OriGene Technologies, Thermo Fisher Scientific, Sigma-Aldrich (Merck), GenScript, VectorBuilder, Cell Biolabs, Allele Biotechnology and Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Lentivirus Preparations market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Custom-made
Pre-made
Market segment by Application
Vitro Animal Studies
In-vivo Animal Studies
Major players covered
Addgene
Abm (Applied Biological Materials)
System Biosciences (SBI)
OriGene Technologies
Thermo Fisher Scientific
Sigma-Aldrich (Merck)
GenScript
VectorBuilder
Cell Biolabs
Allele Biotechnology and Pharmaceuticals
AMSBIO
Creative Biogene
Cellomics Technology
Takara Bio
GeneCopoeia
BPS Bioscience
Santa Cruz Biotechnology
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Lentivirus Preparations product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Lentivirus Preparations, with price, sales quantity, revenue, and global market share of Lentivirus Preparations from 2021 to 2026.
Chapter 3, the Lentivirus Preparations competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lentivirus Preparations breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Lentivirus Preparations market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Lentivirus Preparations.
Chapter 14 and 15, to describe Lentivirus Preparations sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Lentivirus Preparations Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Custom-made
    • 1.3.3 Pre-made
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Lentivirus Preparations Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Vitro Animal Studies
    • 1.4.3 In-vivo Animal Studies
  • 1.5 Global Lentivirus Preparations Market Size & Forecast
    • 1.5.1 Global Lentivirus Preparations Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Lentivirus Preparations Sales Quantity (2021-2032)
    • 1.5.3 Global Lentivirus Preparations Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Addgene
    • 2.1.1 Addgene Details
    • 2.1.2 Addgene Major Business
    • 2.1.3 Addgene Lentivirus Preparations Product and Services
    • 2.1.4 Addgene Lentivirus Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Addgene Recent Developments/Updates
  • 2.2 Abm (Applied Biological Materials)
    • 2.2.1 Abm (Applied Biological Materials) Details
    • 2.2.2 Abm (Applied Biological Materials) Major Business
    • 2.2.3 Abm (Applied Biological Materials) Lentivirus Preparations Product and Services
    • 2.2.4 Abm (Applied Biological Materials) Lentivirus Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Abm (Applied Biological Materials) Recent Developments/Updates
  • 2.3 System Biosciences (SBI)
    • 2.3.1 System Biosciences (SBI) Details
    • 2.3.2 System Biosciences (SBI) Major Business
    • 2.3.3 System Biosciences (SBI) Lentivirus Preparations Product and Services
    • 2.3.4 System Biosciences (SBI) Lentivirus Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 System Biosciences (SBI) Recent Developments/Updates
  • 2.4 OriGene Technologies
    • 2.4.1 OriGene Technologies Details
    • 2.4.2 OriGene Technologies Major Business
    • 2.4.3 OriGene Technologies Lentivirus Preparations Product and Services
    • 2.4.4 OriGene Technologies Lentivirus Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 OriGene Technologies Recent Developments/Updates
  • 2.5 Thermo Fisher Scientific
    • 2.5.1 Thermo Fisher Scientific Details
    • 2.5.2 Thermo Fisher Scientific Major Business
    • 2.5.3 Thermo Fisher Scientific Lentivirus Preparations Product and Services
    • 2.5.4 Thermo Fisher Scientific Lentivirus Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Thermo Fisher Scientific Recent Developments/Updates
  • 2.6 Sigma-Aldrich (Merck)
    • 2.6.1 Sigma-Aldrich (Merck) Details
    • 2.6.2 Sigma-Aldrich (Merck) Major Business
    • 2.6.3 Sigma-Aldrich (Merck) Lentivirus Preparations Product and Services
    • 2.6.4 Sigma-Aldrich (Merck) Lentivirus Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Sigma-Aldrich (Merck) Recent Developments/Updates
  • 2.7 GenScript
    • 2.7.1 GenScript Details
    • 2.7.2 GenScript Major Business
    • 2.7.3 GenScript Lentivirus Preparations Product and Services
    • 2.7.4 GenScript Lentivirus Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 GenScript Recent Developments/Updates
  • 2.8 VectorBuilder
    • 2.8.1 VectorBuilder Details
    • 2.8.2 VectorBuilder Major Business
    • 2.8.3 VectorBuilder Lentivirus Preparations Product and Services
    • 2.8.4 VectorBuilder Lentivirus Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 VectorBuilder Recent Developments/Updates
  • 2.9 Cell Biolabs
    • 2.9.1 Cell Biolabs Details
    • 2.9.2 Cell Biolabs Major Business
    • 2.9.3 Cell Biolabs Lentivirus Preparations Product and Services
    • 2.9.4 Cell Biolabs Lentivirus Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Cell Biolabs Recent Developments/Updates
  • 2.10 Allele Biotechnology and Pharmaceuticals
    • 2.10.1 Allele Biotechnology and Pharmaceuticals Details
    • 2.10.2 Allele Biotechnology and Pharmaceuticals Major Business
    • 2.10.3 Allele Biotechnology and Pharmaceuticals Lentivirus Preparations Product and Services
    • 2.10.4 Allele Biotechnology and Pharmaceuticals Lentivirus Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Allele Biotechnology and Pharmaceuticals Recent Developments/Updates
  • 2.11 AMSBIO
    • 2.11.1 AMSBIO Details
    • 2.11.2 AMSBIO Major Business
    • 2.11.3 AMSBIO Lentivirus Preparations Product and Services
    • 2.11.4 AMSBIO Lentivirus Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 AMSBIO Recent Developments/Updates
  • 2.12 Creative Biogene
    • 2.12.1 Creative Biogene Details
    • 2.12.2 Creative Biogene Major Business
    • 2.12.3 Creative Biogene Lentivirus Preparations Product and Services
    • 2.12.4 Creative Biogene Lentivirus Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Creative Biogene Recent Developments/Updates
  • 2.13 Cellomics Technology
    • 2.13.1 Cellomics Technology Details
    • 2.13.2 Cellomics Technology Major Business
    • 2.13.3 Cellomics Technology Lentivirus Preparations Product and Services
    • 2.13.4 Cellomics Technology Lentivirus Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Cellomics Technology Recent Developments/Updates
  • 2.14 Takara Bio
    • 2.14.1 Takara Bio Details
    • 2.14.2 Takara Bio Major Business
    • 2.14.3 Takara Bio Lentivirus Preparations Product and Services
    • 2.14.4 Takara Bio Lentivirus Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Takara Bio Recent Developments/Updates
  • 2.15 GeneCopoeia
    • 2.15.1 GeneCopoeia Details
    • 2.15.2 GeneCopoeia Major Business
    • 2.15.3 GeneCopoeia Lentivirus Preparations Product and Services
    • 2.15.4 GeneCopoeia Lentivirus Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 GeneCopoeia Recent Developments/Updates
  • 2.16 BPS Bioscience
    • 2.16.1 BPS Bioscience Details
    • 2.16.2 BPS Bioscience Major Business
    • 2.16.3 BPS Bioscience Lentivirus Preparations Product and Services
    • 2.16.4 BPS Bioscience Lentivirus Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 BPS Bioscience Recent Developments/Updates
  • 2.17 Santa Cruz Biotechnology
    • 2.17.1 Santa Cruz Biotechnology Details
    • 2.17.2 Santa Cruz Biotechnology Major Business
    • 2.17.3 Santa Cruz Biotechnology Lentivirus Preparations Product and Services
    • 2.17.4 Santa Cruz Biotechnology Lentivirus Preparations Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Santa Cruz Biotechnology Recent Developments/Updates

3 Competitive Environment: Lentivirus Preparations by Manufacturer

  • 3.1 Global Lentivirus Preparations Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Lentivirus Preparations Revenue by Manufacturer (2021-2026)
  • 3.3 Global Lentivirus Preparations Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Lentivirus Preparations by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Lentivirus Preparations Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Lentivirus Preparations Manufacturer Market Share in 2025
  • 3.5 Lentivirus Preparations Market: Overall Company Footprint Analysis
    • 3.5.1 Lentivirus Preparations Market: Region Footprint
    • 3.5.2 Lentivirus Preparations Market: Company Product Type Footprint
    • 3.5.3 Lentivirus Preparations Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Lentivirus Preparations Market Size by Region
    • 4.1.1 Global Lentivirus Preparations Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Lentivirus Preparations Consumption Value by Region (2021-2032)
    • 4.1.3 Global Lentivirus Preparations Average Price by Region (2021-2032)
  • 4.2 North America Lentivirus Preparations Consumption Value (2021-2032)
  • 4.3 Europe Lentivirus Preparations Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Lentivirus Preparations Consumption Value (2021-2032)
  • 4.5 South America Lentivirus Preparations Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Lentivirus Preparations Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Lentivirus Preparations Sales Quantity by Type (2021-2032)
  • 5.2 Global Lentivirus Preparations Consumption Value by Type (2021-2032)
  • 5.3 Global Lentivirus Preparations Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Lentivirus Preparations Sales Quantity by Application (2021-2032)
  • 6.2 Global Lentivirus Preparations Consumption Value by Application (2021-2032)
  • 6.3 Global Lentivirus Preparations Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Lentivirus Preparations Sales Quantity by Type (2021-2032)
  • 7.2 North America Lentivirus Preparations Sales Quantity by Application (2021-2032)
  • 7.3 North America Lentivirus Preparations Market Size by Country
    • 7.3.1 North America Lentivirus Preparations Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Lentivirus Preparations Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Lentivirus Preparations Sales Quantity by Type (2021-2032)
  • 8.2 Europe Lentivirus Preparations Sales Quantity by Application (2021-2032)
  • 8.3 Europe Lentivirus Preparations Market Size by Country
    • 8.3.1 Europe Lentivirus Preparations Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Lentivirus Preparations Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Lentivirus Preparations Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Lentivirus Preparations Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Lentivirus Preparations Market Size by Region
    • 9.3.1 Asia-Pacific Lentivirus Preparations Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Lentivirus Preparations Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Lentivirus Preparations Sales Quantity by Type (2021-2032)
  • 10.2 South America Lentivirus Preparations Sales Quantity by Application (2021-2032)
  • 10.3 South America Lentivirus Preparations Market Size by Country
    • 10.3.1 South America Lentivirus Preparations Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Lentivirus Preparations Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Lentivirus Preparations Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Lentivirus Preparations Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Lentivirus Preparations Market Size by Country
    • 11.3.1 Middle East & Africa Lentivirus Preparations Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Lentivirus Preparations Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Lentivirus Preparations Market Drivers
  • 12.2 Lentivirus Preparations Market Restraints
  • 12.3 Lentivirus Preparations Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Lentivirus Preparations and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Lentivirus Preparations
  • 13.3 Lentivirus Preparations Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Lentivirus Preparations Typical Distributors
  • 14.3 Lentivirus Preparations Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Lentivirus Preparations. Industry analysis & Market Report on Lentivirus Preparations is a syndicated market report, published as Global Lentivirus Preparations Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Lentivirus Preparations market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report